drugset
drugset / Trial / NCT01773005

Caldolor Versus Caldolor Plus OFIRMEV in Total Knee or Hip Arthroplasty Surgeries

NCT01773005 ↗

Phase 4 Completed 78 enrolled Anita Gupta Cumberland Pharmaceuticals · collab
RandomizedParallel-groupSingle-blindSupportive care

Summary

The objective of this study is to compare the effectiveness and of perioperative use of Caldolor alone and in combination with OFIRMEV in total knee or hip arthroplasty procedures.

Timeline

Start
2012-12
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 1000 mg Intravenous
Comparator Ibuprofen Small molecule 800 mg Intravenous

Indications

No indication recorded.